PA8469301A1 - Procedimientos para la preparacion de acidos hidroxamicos. - Google Patents

Procedimientos para la preparacion de acidos hidroxamicos.

Info

Publication number
PA8469301A1
PA8469301A1 PA19998469301A PA8469301A PA8469301A1 PA 8469301 A1 PA8469301 A1 PA 8469301A1 PA 19998469301 A PA19998469301 A PA 19998469301A PA 8469301 A PA8469301 A PA 8469301A PA 8469301 A1 PA8469301 A1 PA 8469301A1
Authority
PA
Panama
Prior art keywords
preparation
hydroxamic acids
procedures
replacements
intermediates
Prior art date
Application number
PA19998469301A
Other languages
English (en)
Spanish (es)
Inventor
Joel Michael Hawkins
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8469301A1 publication Critical patent/PA8469301A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/14—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
PA19998469301A 1998-04-10 1999-03-19 Procedimientos para la preparacion de acidos hidroxamicos. PA8469301A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8136598P 1998-04-10 1998-04-10

Publications (1)

Publication Number Publication Date
PA8469301A1 true PA8469301A1 (es) 2000-09-29

Family

ID=22163686

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19998469301A PA8469301A1 (es) 1998-04-10 1999-03-19 Procedimientos para la preparacion de acidos hidroxamicos.

Country Status (38)

Country Link
US (1) US6288246B1 (OSRAM)
EP (1) EP0949244A3 (OSRAM)
JP (1) JPH11343277A (OSRAM)
KR (1) KR100329902B1 (OSRAM)
CN (1) CN1232023A (OSRAM)
AP (1) AP1203A (OSRAM)
AR (1) AR018180A1 (OSRAM)
AU (1) AU747629B2 (OSRAM)
BG (1) BG64154B1 (OSRAM)
BR (1) BR9901089A (OSRAM)
CA (1) CA2268680A1 (OSRAM)
CO (1) CO5070713A1 (OSRAM)
DZ (1) DZ2757A1 (OSRAM)
EA (1) EA002777B1 (OSRAM)
EG (1) EG22263A (OSRAM)
GT (1) GT199900046A (OSRAM)
HR (1) HRP990105A2 (OSRAM)
HU (1) HUP9901041A3 (OSRAM)
ID (1) ID23337A (OSRAM)
IL (1) IL129328A0 (OSRAM)
IN (1) IN192342B (OSRAM)
IS (1) IS5019A (OSRAM)
MA (1) MA24831A1 (OSRAM)
NO (1) NO991672L (OSRAM)
NZ (1) NZ335104A (OSRAM)
OA (1) OA11031A (OSRAM)
PA (1) PA8469301A1 (OSRAM)
PE (1) PE20000418A1 (OSRAM)
PL (1) PL332450A1 (OSRAM)
SG (1) SG125880A1 (OSRAM)
SK (1) SK43699A3 (OSRAM)
TN (1) TNSN99052A1 (OSRAM)
TR (1) TR199900755A2 (OSRAM)
TW (1) TW448147B (OSRAM)
UA (1) UA57750C2 (OSRAM)
UY (1) UY25460A1 (OSRAM)
YU (1) YU18199A (OSRAM)
ZA (1) ZA992631B (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
US6458822B2 (en) 2000-03-13 2002-10-01 Pfizer Inc. 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
GB0103303D0 (en) 2001-02-09 2001-03-28 Novartis Ag Organic compounds
WO2004106319A1 (en) * 2003-05-30 2004-12-09 Pfizer Products Inc. Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide
RU2326862C2 (ru) * 2003-08-29 2008-06-20 Басф Акциенгезельшафт Способ получения о-замещенных гидроксиламиновых соединений
WO2015094739A1 (en) 2013-12-18 2015-06-25 Brita Lp Lid for filter-as-you-pour container system
TW202237119A (zh) 2020-12-10 2022-10-01 美商住友製藥腫瘤公司 Alk﹘5抑制劑和彼之用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794723B (en) 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
GB9000725D0 (en) 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
US5552419A (en) * 1993-01-06 1996-09-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
PL331895A1 (en) 1996-08-23 1999-08-16 Pfizer Arylosulphonylamino derivatives of hydroxamic acid
AU721748B2 (en) 1997-02-03 2000-07-13 Pfizer Products Inc. Arylsulfonylamino hydroxamic acid derivatives
ID23668A (id) 1997-08-08 2000-05-11 Pfizer Prod Inc Turunan asam ariloksiarilsulfonilamino hidroksamat
ES2176913T3 (es) 1997-08-08 2002-12-01 Pfizer Prod Inc Derivados de acidos arilsulfonilaminohidroxamicos.
PA8469401A1 (es) 1998-04-10 2000-05-24 Pfizer Prod Inc Derivados biciclicos del acido hidroxamico

Also Published As

Publication number Publication date
KR19990083051A (ko) 1999-11-25
HRP990105A2 (en) 2000-02-29
PL332450A1 (en) 1999-10-11
EP0949244A3 (en) 2001-05-30
IN192342B (OSRAM) 2004-04-10
NZ335104A (en) 2000-10-27
EA002777B1 (ru) 2002-08-29
EG22263A (en) 2002-11-30
US6288246B1 (en) 2001-09-11
KR100329902B1 (ko) 2002-03-22
CN1232023A (zh) 1999-10-20
EA199900284A2 (ru) 1999-10-28
IS5019A (is) 1999-10-11
GT199900046A (es) 2000-09-15
AP1203A (en) 2003-09-05
YU18199A (sh) 2002-11-15
SK43699A3 (en) 2000-06-12
AP9901503A0 (en) 1999-06-30
OA11031A (en) 2002-02-07
CO5070713A1 (es) 2001-08-28
TR199900755A3 (tr) 1999-11-22
AR018180A1 (es) 2001-10-31
SG125880A1 (en) 2006-10-30
JPH11343277A (ja) 1999-12-14
TNSN99052A1 (fr) 2005-11-10
BG103319A (en) 2001-08-31
UA57750C2 (uk) 2003-07-15
BR9901089A (pt) 2000-05-30
ID23337A (id) 2000-04-05
AU2369099A (en) 1999-10-21
HU9901041D0 (en) 1999-06-28
DZ2757A1 (fr) 2003-09-15
HUP9901041A2 (hu) 2000-03-28
NO991672L (no) 1999-10-11
IL129328A0 (en) 2000-02-17
UY25460A1 (es) 1999-11-17
AU747629B2 (en) 2002-05-16
EP0949244A2 (en) 1999-10-13
MA24831A1 (fr) 1999-12-31
BG64154B1 (bg) 2004-02-27
NO991672D0 (no) 1999-04-09
CA2268680A1 (en) 1999-10-10
TR199900755A2 (xx) 1999-11-22
EA199900284A3 (ru) 2000-04-24
ZA992631B (en) 2000-10-09
HUP9901041A3 (en) 2003-02-28
TW448147B (en) 2001-08-01
PE20000418A1 (es) 2000-05-23

Similar Documents

Publication Publication Date Title
GT200000190A (es) Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas-4-carboxiamino-2-sustituidas.
BRPI0413498A (pt) método para produzir um éster de ácido carboxìlico substituìdo por hidróxi, ciano vicinal a partir de um éster de ácido carboxìlico substituìdo por hidróxi, halo vicinal, e, composição
ES2166916T3 (es) Procedimiento para la purificacion de diarilesteres del acido carbonico.
BR0010555A (pt) Inibidores de neuraminidases
BR9802011A (pt) Processo para a produção de vanilina.
EA200300703A1 (ru) Пищевая композиция, подходящая для поверхностного обжаривания, включающая лецитин подсолнечника
WO2004050620A3 (en) Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
MX2009007422A (es) Proceso mejorado para la preparacion de fosfolipidos oxidados.
PE20061427A1 (es) Metodos para identificar objetivos terapeuticos para el tratamiento de la atrofia vulvovaginal
BR9713261A (pt) Tricìclicos substituìdos
CU22953A3 (es) Procedimiento para la preparación de ácidos 8-metoxiquinoloncarboxílicos
AR036685A1 (es) Un procedimiento para la preparacion de esteres policarboxilicos aliciclicos a partir de esteres parciales de acidos policarboxilicos aromaticos
UY38895A (es) PROCESO PARA PREPARAR (15a,16a,17ß)-ESTRA-1,3,5(10)-TRIENO-3,15,16,17-TETROL (ESTETROL) E INTERMEDIOS DE DICHO PROCESO
ES2184896T3 (es) Procedimiento para la obtencion de ciclodepsipeptidos con 24 atomos en el anillo, que contienen acidos aril-lacticos substituidos.
GT199900046A (es) Procedimiento para la preparaciòn deacidos hidroxàmicos.
BR9912556A (pt) Triazolpiridinas para o tratamento de distúrbios trombóticos
EP2604614A3 (en) Oxidized phospholipids
ES2183162T3 (es) Ester de oxazolidina.
ECSP992914A (es) Procedimiento para la preparacion de acidos hidroxamicos
CY1111730T1 (el) Διαδικασια για την παρασκευη γκαμπαπεντινης
ES2173399T3 (es) Procedimiento para la sintesis de benzotiofenos.
TW200724567A (en) Amide-containing polymers for rheology control
AU8294401A (en) A process for the preparation of alpha' chloroketones
BRPI0413686A (pt) processo para a preparação ésteres dialquìlicos de ácido alfa-fluormalÈnico
AR025028A1 (es) Procedimiento para preparar acidos a traves de alfa-cloroepoxi-esteres